HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal Melanoma
Clinical trial NCT03435302 · UNKNOWN
Trial details
- NCT number
- NCT03435302
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2018-02-01
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.